Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1375552 | Bioorganic & Medicinal Chemistry Letters | 2009 | 4 Pages |
Disruption of protein–protein interactions by small molecules is achievable but presents significant hurdles for effective compound design. In earlier work we identified a series of thiazolidinone inhibitors of the bacterial type III secretion system (T3SS) and demonstrated that this scaffold had the potential to be expanded into molecules with broad-spectrum anti-Gram negative activity. We now report on one series of thiazolidinone analogs in which the heterocycle is presented as a dimer at the termini of a series of linkers. Many of these dimers inhibited the T3SS-dependent secretion of a virulence protein at concentrations lower than that of the original monomeric compound identified in our screen.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide